A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy

Uveal melanoma (UM) is an intraocular malignancy with poor survival rates due to the propensity for metastatic spread. Although treatment options exist for localized disease, there are fewer definitive guidelines for metastatic UM. Treatment involves a personalized approach that entails patient-spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2022-06, Vol.14 (6)
Hauptverfasser: Fadel, Celine A, Kanakamedala, Swathi, Danak, Shivang U, Johnson, Andrew T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Fadel, Celine A
Kanakamedala, Swathi
Danak, Shivang U
Johnson, Andrew T
description Uveal melanoma (UM) is an intraocular malignancy with poor survival rates due to the propensity for metastatic spread. Although treatment options exist for localized disease, there are fewer definitive guidelines for metastatic UM. Treatment involves a personalized approach that entails patient-specific aspects, including tumor genetics. This case highlights the disease course of a 60-year-old male diagnosed with stage IIB right eye choroidal melanoma. Despite successful therapy for localized UM, he developed widespread metastasis. He received dual immunotherapy and was ultimately maintained on a single-agent regimen. His prognosis has surpassed initial prognosis and survival expectations. This case highlights the use of immunotherapy, both dual and single therapy, to treat this rare malignancy and extend overall survival.
doi_str_mv 10.7759/cureus.26146
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2696786153</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-28a3d21fa1fb73ea4dd9cef07dfb129cf35f6d08199b161bc86ac70d1a82d4183</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMottTe_AELXm3NZLdJ9iKU-gkVodhzmM1Hu6W7qcluof_e1RbR0wwzL88MDyHXQMdCTPI73QbbxjHjkPEz0mfA5UiCzM7_9D0yjHFDKQUqGBX0kvTSicxBMtonD9NkgcEmM4w28S55sw3GBptSJ8u9xW032GLtK0wWNu58bcp6lTQ-ea2qtvbN2gbcHa7IhcNttMNTHZDl0-PH7GU0f39-nU3nI80kb0ZMYmoYOARXiNRiZkyuraPCuAJYrl06cdxQCXleAIdCS45aUAMomclApgNyf-Tu2qKyRtu6CbhVu1BWGA7KY6n-b-pyrVZ-r_KUAhdZB7g5AYL_bG1s1Ma3oe5-VoznXEgOk7RL3R5TOvgYg3W_F4Cqb-3qqF39aE-_ABWddf8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2696786153</pqid></control><display><type>article</type><title>A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Fadel, Celine A ; Kanakamedala, Swathi ; Danak, Shivang U ; Johnson, Andrew T</creator><creatorcontrib>Fadel, Celine A ; Kanakamedala, Swathi ; Danak, Shivang U ; Johnson, Andrew T</creatorcontrib><description>Uveal melanoma (UM) is an intraocular malignancy with poor survival rates due to the propensity for metastatic spread. Although treatment options exist for localized disease, there are fewer definitive guidelines for metastatic UM. Treatment involves a personalized approach that entails patient-specific aspects, including tumor genetics. This case highlights the disease course of a 60-year-old male diagnosed with stage IIB right eye choroidal melanoma. Despite successful therapy for localized UM, he developed widespread metastasis. He received dual immunotherapy and was ultimately maintained on a single-agent regimen. His prognosis has surpassed initial prognosis and survival expectations. This case highlights the use of immunotherapy, both dual and single therapy, to treat this rare malignancy and extend overall survival.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.26146</identifier><identifier>PMID: 35891820</identifier><language>eng</language><publisher>Palo Alto: Cureus Inc</publisher><subject>Abdomen ; Angiogenesis ; Biopsy ; Case reports ; Chemotherapy ; Cytotoxicity ; Immunotherapy ; Internal Medicine ; Liver ; Magnetic resonance imaging ; Medical prognosis ; Melanoma ; Metastasis ; Mutation ; Oncology ; Ophthalmology ; Patients ; Radiation therapy ; Skin cancer ; Tomography ; Tumors ; Vascular endothelial growth factor ; White people</subject><ispartof>Curēus (Palo Alto, CA), 2022-06, Vol.14 (6)</ispartof><rights>Copyright © 2022, Fadel et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Fadel et al. 2022 Fadel et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c286t-28a3d21fa1fb73ea4dd9cef07dfb129cf35f6d08199b161bc86ac70d1a82d4183</citedby><cites>FETCH-LOGICAL-c286t-28a3d21fa1fb73ea4dd9cef07dfb129cf35f6d08199b161bc86ac70d1a82d4183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301674/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301674/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids></links><search><creatorcontrib>Fadel, Celine A</creatorcontrib><creatorcontrib>Kanakamedala, Swathi</creatorcontrib><creatorcontrib>Danak, Shivang U</creatorcontrib><creatorcontrib>Johnson, Andrew T</creatorcontrib><title>A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy</title><title>Curēus (Palo Alto, CA)</title><description>Uveal melanoma (UM) is an intraocular malignancy with poor survival rates due to the propensity for metastatic spread. Although treatment options exist for localized disease, there are fewer definitive guidelines for metastatic UM. Treatment involves a personalized approach that entails patient-specific aspects, including tumor genetics. This case highlights the disease course of a 60-year-old male diagnosed with stage IIB right eye choroidal melanoma. Despite successful therapy for localized UM, he developed widespread metastasis. He received dual immunotherapy and was ultimately maintained on a single-agent regimen. His prognosis has surpassed initial prognosis and survival expectations. This case highlights the use of immunotherapy, both dual and single therapy, to treat this rare malignancy and extend overall survival.</description><subject>Abdomen</subject><subject>Angiogenesis</subject><subject>Biopsy</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Immunotherapy</subject><subject>Internal Medicine</subject><subject>Liver</subject><subject>Magnetic resonance imaging</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Ophthalmology</subject><subject>Patients</subject><subject>Radiation therapy</subject><subject>Skin cancer</subject><subject>Tomography</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>White people</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkE1LAzEQhoMottTe_AELXm3NZLdJ9iKU-gkVodhzmM1Hu6W7qcluof_e1RbR0wwzL88MDyHXQMdCTPI73QbbxjHjkPEz0mfA5UiCzM7_9D0yjHFDKQUqGBX0kvTSicxBMtonD9NkgcEmM4w28S55sw3GBptSJ8u9xW032GLtK0wWNu58bcp6lTQ-ea2qtvbN2gbcHa7IhcNttMNTHZDl0-PH7GU0f39-nU3nI80kb0ZMYmoYOARXiNRiZkyuraPCuAJYrl06cdxQCXleAIdCS45aUAMomclApgNyf-Tu2qKyRtu6CbhVu1BWGA7KY6n-b-pyrVZ-r_KUAhdZB7g5AYL_bG1s1Ma3oe5-VoznXEgOk7RL3R5TOvgYg3W_F4Cqb-3qqF39aE-_ABWddf8</recordid><startdate>20220621</startdate><enddate>20220621</enddate><creator>Fadel, Celine A</creator><creator>Kanakamedala, Swathi</creator><creator>Danak, Shivang U</creator><creator>Johnson, Andrew T</creator><general>Cureus Inc</general><general>Cureus</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20220621</creationdate><title>A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy</title><author>Fadel, Celine A ; Kanakamedala, Swathi ; Danak, Shivang U ; Johnson, Andrew T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-28a3d21fa1fb73ea4dd9cef07dfb129cf35f6d08199b161bc86ac70d1a82d4183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Abdomen</topic><topic>Angiogenesis</topic><topic>Biopsy</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Immunotherapy</topic><topic>Internal Medicine</topic><topic>Liver</topic><topic>Magnetic resonance imaging</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Ophthalmology</topic><topic>Patients</topic><topic>Radiation therapy</topic><topic>Skin cancer</topic><topic>Tomography</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>White people</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fadel, Celine A</creatorcontrib><creatorcontrib>Kanakamedala, Swathi</creatorcontrib><creatorcontrib>Danak, Shivang U</creatorcontrib><creatorcontrib>Johnson, Andrew T</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fadel, Celine A</au><au>Kanakamedala, Swathi</au><au>Danak, Shivang U</au><au>Johnson, Andrew T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><date>2022-06-21</date><risdate>2022</risdate><volume>14</volume><issue>6</issue><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Uveal melanoma (UM) is an intraocular malignancy with poor survival rates due to the propensity for metastatic spread. Although treatment options exist for localized disease, there are fewer definitive guidelines for metastatic UM. Treatment involves a personalized approach that entails patient-specific aspects, including tumor genetics. This case highlights the disease course of a 60-year-old male diagnosed with stage IIB right eye choroidal melanoma. Despite successful therapy for localized UM, he developed widespread metastasis. He received dual immunotherapy and was ultimately maintained on a single-agent regimen. His prognosis has surpassed initial prognosis and survival expectations. This case highlights the use of immunotherapy, both dual and single therapy, to treat this rare malignancy and extend overall survival.</abstract><cop>Palo Alto</cop><pub>Cureus Inc</pub><pmid>35891820</pmid><doi>10.7759/cureus.26146</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-06, Vol.14 (6)
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9301674
source PubMed Central Open Access; PubMed Central
subjects Abdomen
Angiogenesis
Biopsy
Case reports
Chemotherapy
Cytotoxicity
Immunotherapy
Internal Medicine
Liver
Magnetic resonance imaging
Medical prognosis
Melanoma
Metastasis
Mutation
Oncology
Ophthalmology
Patients
Radiation therapy
Skin cancer
Tomography
Tumors
Vascular endothelial growth factor
White people
title A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A47%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Rare%20Case%20of%20Metastatic%20Uveal%20Melanoma%20Responding%20to%20Immunotherapy&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Fadel,%20Celine%20A&rft.date=2022-06-21&rft.volume=14&rft.issue=6&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.26146&rft_dat=%3Cproquest_pubme%3E2696786153%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2696786153&rft_id=info:pmid/35891820&rfr_iscdi=true